Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00943085 · ClinicalTrials.gov registry record · NA

Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder

A NA study of Bipolar Disorder, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
52
Enrollment target
2
Study locations

NCT00943085 is a NA study of Bipolar Disorder that has completed, run by University of California, Los Angeles. The registered enrollment target is 52 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00943085, a NA study of Bipolar Disorder, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
2
Study locations

Study Summary

This study will test a family-based therapy aimed at preventing or reducing the symptoms of bipolar disorder in at-risk children.

Conditions Studied

Interventions

  • BEHAVIORAL Family-focused therapy
  • BEHAVIORAL Brief educational treatment

Study Locations (2)

California

  • Stanford University School of Medicine, Lucile Packard Children's Hospital - Stanford

Colorado

  • University of Colorado, Boulder - Boulder

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2007-04
Est. Completion 2011-08
Phase NA

What the Registry Record Tells You About NCT00943085

The ClinicalTrials.gov registry entry for NCT00943085 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (84% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Family-focused therapy is the first listed.

NCT00943085 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Colorado.

Frequently Asked Questions

What is clinical trial NCT00943085 about?

NCT00943085 is a clinical study titled "Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder". This study will test a family-based therapy aimed at preventing or reducing the symptoms of bipolar disorder in at-risk children.

What is the current status of trial NCT00943085?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2007-04. Estimated completion is 2011-08.

What conditions does trial NCT00943085 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT00943085?

The interventions under investigation include: Family-focused therapy (BEHAVIORAL), Brief educational treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00943085?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00943085 being conducted?

This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.